TOP STORIES

• BUSINESS Chugai, Teijin Suffer Hefty 9% Cuts in 2020 Drug Price Revision: Jiho Poll
  March 6, 2020

• REGULATORY Xolair Faces 37.3% Price Slash, Keytruda 20.9% in April: MHLW
  March 5, 2020

• BUSINESS Sumitomo Dainippon Creates Chief Scientific Officer Post to Optimize Portfolio
  March 4, 2020

• BUSINESS Vital-Net to Create 20-Strong Team of “Regenerative Medicine Liaisons”
  March 3, 2020

• BUSINESS Xolair’s Re-Pricing Decided, but Regulators and Novartis Were at Odds over Patient Projections
  March 2, 2020

• BUSINESS MSD Japan Embarking on 2-Step Spinoff for Women’s Health, Legacy Brands
  February 28, 2020

• BUSINESS Japan Drug Makers Fearing Manufacturing Crisis as Coronavirus Spreads
  February 27, 2020

• REGULATORY Zolgensma Now in Line for Japan Approval in March, All Eyes Now Riveted on Price
  February 27, 2020

• BUSINESS Fujifilm Receives Avigan Supply Requests from Overseas amid Coronavirus Outbreak
  February 27, 2020

• BUSINESS Drug Makers in Japan Upping Coronavirus Measures; Takeda Switches to Online Interviews for New R&D Hires
  February 26, 2020

• REGULATORY Japan Approves Label Expansions for Rozlytrek, Alecensa and More
  February 25, 2020

• BUSINESS “Tender Process Needs to Be Improved” in Response to Bid-Rigging Scandal by Top 4 Wholesalers: Hospital Management Advisor
  February 25, 2020

• ORGANIZATION Japan Pharma Lobbies Likely to Retain Chiefs as Off-Year Re-Pricing Debate Looms
  February 21, 2020

• BUSINESS Takeda Vaults to 9th in Global Pharma Ranking after Shire Buy, Roche Tops List: Jiho Tally
  February 21, 2020

• BUSINESS GSK Japan Resurrects “Sales” for Rep Performance Review, Doctor Payments; Critics Say It’s a Rollback
  February 20, 2020

• BUSINESS Japan Pharma Market Logs 1st Growth in 3 Years in 2019, Keytruda Is the Best-Seller: IQVIA
  February 19, 2020

• REGULATORY Authorized Generics for Memary, Celecox among Approval List towards June Listing
  February 18, 2020

• REGULATORY MHLW Panel to Review Nippon Shinyaku’s Oligonucleotide DMD Drug, Latuda and More on Feb. 28
  February 18, 2020

• REGULATORY Zolgensma Up for Japan Advisory Panel Meeting on Feb. 26, Listing Expected as Early as May
  February 17, 2020

• BUSINESS Eisai Pulls Belviq from US Market after FDA Flags Cancer Risks
  February 17, 2020

ページ

• « 先頭
• ‹ Prev
• …
• 110
• 111
• 112
• 113
• 114
• 115
• 116
• 117
• 118
• …
• Next ›
• 最終 »